Ara
Toplam kayıt 2, listelenen: 1-2
Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: A descriptive analysis of the Eurobact II study
(BioMed Central Ltd, 2022)
Background: The study aimed to describe the epidemiology and outcomes of hospital-acquired bloodstream infections (HABSIs) between COVID-19 and non-COVID-19 critically ill patients. Methods: We used data from the Eurobact ...
Evaluation of drug-drug interactions and side effects in COVID-19 patients in an intensive care unit
(Galenos Publishing House, 2022)
BACKGROUND/AIM: Considering comorbidity rates in patients diagnosed with coronavirus disease 2019 (COVID-19), polypharmacy will be inevitable when the treatment for COVID-19 is added to the treatment of existing chronic ...